Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Bladder Cancer

Free Subscription 01.09.2025 1 Am J Clin Pathol 1 Bioengineering (Basel) 1 Bladder Cancer 2 Cancer Genomics Proteomics 2 Cancers (Basel) 1 Cureus 1 Curr Oncol 1 Eur J Oncol Nurs 2 Front Immunol 1 Immunity 1 Int Braz J Urol 1 Int J Clin Oncol 1 Int Urol Nephrol 1 Iran J Med Sci 1 J Cancer 2 J Clin Med 1 J Ethnopharmacol 1 Korean J Radiol 1 Malays J Pathol 1 Medicina (Kaunas) 1 Nat Commun 1 Neurol Sci 1 Pharmaceuticals (Basel) 1 Psychopharmacology (Berl) 1 Sci Rep 1 World J Urol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Clin Pathol

1. RIZKALLA CN, Tretiakova M, Suarez CJ, Williamson SR, et al
   Urothelial carcinoma with osteoclast-like giant cells: An expanded immunohistochemical and molecular profile.
   Am J Clin Pathol. 2025;164:257-264.
   PubMed         Abstract available
   
   

   
   Bioengineering (Basel)

2. VERA G, Cerda-Infante J, Fernandez MI, Sanchez-Encinas M, et al
   Advances in Label-Free Detection of Non-Muscle Invasive Bladder Cancer: A Critical Review.
   Bioengineering (Basel). 2025;12:866.
   PubMed         Abstract available
   
   

   
   Bladder Cancer

3. JOHANSSON HB, Liedberg F, Bernardo C, Zadoroznyj A, et al
   Evaluation of gene expression-based predictors of lymph node metastasis in bladder cancer.
   Bladder Cancer. 2025;11:23523735251370895.
   PubMed         Abstract available
   
   

   
   Cancer Genomics Proteomics

4. QUYNH NT, Nagata Y, Matsukawa T, Kashiwagi E, et al
   Pioglitazone Suppresses Urothelial Tumorigenesis In Vitro: A Potential Chemopreventive Agent.
   Cancer Genomics Proteomics. 2025;22:750-759.
   PubMed         Abstract available
   
   
5. NAHKURI S, Weidle UH
   Bladder Cancer: Role of Circular RNAs in Oncogenesis, Tumor Suppression, and Therapeutic Target Identification.
   Cancer Genomics Proteomics. 2025;22:654-682.
   PubMed         Abstract available
   
   

   
   Cancers (Basel)

6. ARTILES MEDINA A, Bajawi Carretero M, Lopez Perez E, Garach Fernandez S, et al
   Impact of Preoperative CT-Diagnosed Sarcopenic Obesity on Outcomes After Radical Cystectomy for Bladder Cancer.
   Cancers (Basel). 2025;17:2669.
   PubMed         Abstract available
   
   
7. SHABBIR R, Quiles CG, Lane B, Zeef L, et al
   Gene Expression in Muscle-Invasive and Non-Muscle-Invasive Bladder Cancer Cells Exposed to Hypoxia.
   Cancers (Basel). 2025;17:2624.
   PubMed         Abstract available
   
   

   
   Cureus

8. AKINTELURE D, Akintelure S, Al-Ibraheem HA
   Emerging Role of Multiparametric MRI in the Staging of Bladder Cancer: Insights From the BladderPath Trial.
   Cureus. 2025;17:e88623.
   PubMed         Abstract available
   
   

   
   Curr Oncol

9. IKUMA S, Akatsuka J, Kaneko G, Takeda H, et al
   Prognostic Utility of Combining VI-RADS Scores and CYFRA 21-1 Levels in Bladder Cancer: A Retrospective Single-Center Study.
   Curr Oncol. 2025;32:415.
   PubMed         Abstract available
   
   

   
   Eur J Oncol Nurs

10. JANG SH, Kim MS
    Canonical correlations among symptom clusters, symptom experience, and symptom cluster management in male patients with non-muscle invasive bladder cancer: a cross-sectional study.
    Eur J Oncol Nurs. 2025;78:102941.
    PubMed         Abstract available
    
    

    
    Front Immunol

11. LIU Z, Cong X, Chen C, Yin J, et al
    Development and landscape of maintenance therapy after first-line treatment of advanced or metastatic urothelial carcinoma.
    Front Immunol. 2025;16:1541213.
    PubMed         Abstract available
    
    
12. CHEN B, Zhang T, Wang Y, Li Z, et al
    Elevated C-reactive protein and D-dimer to predict venous thromboembolism in patients with bladder cancer.
    Front Immunol. 2025;16:1652139.
    PubMed         Abstract available
    
    

    
    Immunity

13. JURADO LF, Daman AW, Li Z, Ross VMS, et al
    A fungal-derived adjuvant amplifies the antitumoral potency of Bacillus Calmette-Guerin via reprogramming granulopoiesis.
    Immunity. 2025;58:1984-2001.
    PubMed         Abstract available
    
    

    
    Int Braz J Urol

14. HAN G, Wang X, Li Z, Yang K, et al
    Robot-Assisted Boari-flap after Orthotopic Neobladder Using the KangDuo Surgical Robot-01 System.
    Int Braz J Urol. 2026;52:e20250341.
    PubMed         Abstract available
    
    

    
    Int J Clin Oncol

15. ATSUTA M, Urabe F, Iwatani K, Kubo M, et al
    Clinical utility of a novel perioperative quality assessment metric, trifecta, for radical cystectomy.
    Int J Clin Oncol. 2025;30:1832-1840.
    PubMed         Abstract available
    
    

    
    Int Urol Nephrol

16. YILDIZ AK, Bayraktar A, Kacan T, Demir DO, et al
    Two different protocols in single, immediate, postoperative intravesical chemotherapy after transurethral resection in suspected, low-risk, non-muscle-invasive bladder cancer.
    Int Urol Nephrol. 2025 Aug 28. doi: 10.1007/s11255-025-04767.
    PubMed         Abstract available
    
    

    
    Iran J Med Sci

17. MAHMOUDNEJAD N, Hamidi Madani M, Montazeri P, Vakili K, et al
    Clinical Predictive Factors for Reproductive Organ Involvement in Females with Muscle Invasive Bladder Cancer: A Retrospective Review of Radical Cystectomy Cases from Two Tertiary Centers.
    Iran J Med Sci. 2025;50:530-538.
    PubMed         Abstract available
    
    

    
    J Cancer

18. TSENG WH, Lee CH, Lin RJ, Ho CH, et al
    Risk of Bladder Cancer in Patients with Chronic Indwelling Catheters: A Real-World Data Analysis.
    J Cancer. 2025;16:3464-3472.
    PubMed         Abstract available
    
    

    
    J Clin Med

19. GARCIA-RAYO C, Juste-Alvarez S, Gomez-Canizo C, Hernandez-Arroyo M, et al
    The Dynamic Field of Perioperative Treatment for Localized Muscle-Invasive Bladder Cancer: A Review of the Current Research Landscape.
    J Clin Med. 2025;14:5653.
    PubMed         Abstract available
    
    
20. DULF DV, Burnar AL, Dulf PL, Matei DR, et al
    Risk Stratification Using a Perioperative Nomogram for Predicting the Mortality of Bladder Cancer Patients Undergoing Radical Cystectomy.
    J Clin Med. 2025;14:5810.
    PubMed         Abstract available
    
    

    
    J Ethnopharmacol

21. LIU J, Liu YX, Song YS, Liu CK, et al
    Targeting GRB2-Akt-SREBP1 signaling axis by saponins from Paris polyphylla Smith var. yunnanensis (Franch.) Hand.-Mazz to overcome cisplatin resistance in bladder cancer.
    J Ethnopharmacol. 2025 Aug 27:120502. doi: 10.1016/j.jep.2025.120502.
    PubMed         Abstract available
    
    

    
    Korean J Radiol

22. HAN YE, Sung DJ, Cho HY, Yang KS, et al
    Multiparametric MRI Features of Plasmacytoid Urothelial Carcinoma of the Urinary Bladder.
    Korean J Radiol. 2025;26:832-840.
    PubMed         Abstract available
    
    

    
    Malays J Pathol

23. KIM JM, Park S
    Risk stratification of pT1b urothelial carcinoma based on spatial relationships between invasive tumour and muscularis propria on TURB specimens for predicting muscle-invasive urothelial carcinoma in radical cystectomy: A new proposal.
    Malays J Pathol. 2025;47:247-252.
    PubMed         Abstract available
    
    

    
    Medicina (Kaunas)

24. GHERASIM RD, Chibelean C, Porav-Hodade D, Todea-Moga C, et al
    Microbiome Shifts in Bladder Cancer: A Narrative Review of Urobiome Composition, Progression, and Therapeutic Impact.
    Medicina (Kaunas). 2025;61:1401.
    PubMed         Abstract available
    
    

    
    Nat Commun

25. KAMATANI T, Umeda K, Iwasawa T, Miya F, et al
    Clonal diversity shapes the tumour microenvironment leading to distinct immunotherapy responses in metastatic urothelial carcinoma.
    Nat Commun. 2025;16:7995.
    PubMed         Abstract available
    
    

    
    Neurol Sci

26. CORDARO F, Barresi A, Bencivinni F, Banco A, et al
    Carcinomatous leptomeningitis from bladder cancer mimicking immune-related cerebellitis: A case report.
    Neurol Sci. 2025 Aug 27. doi: 10.1007/s10072-025-08425.
    PubMed         Abstract available
    
    

    
    Pharmaceuticals (Basel)

27. LI Y, Liu S, Zhou M, Zhao Z, et al
    A COX-2-Targeted Platinum(lV) Prodrug Induces Apoptosis and Reduces Inflammation in Bladder Cancer Models.
    Pharmaceuticals (Basel). 2025;18:1185.
    PubMed         Abstract available
    
    

    
    Psychopharmacology (Berl)

28. SU X, Mo X, Kan J, Yang F, et al
    Decoding the genetic links between substance use disorder and cancer vulnerability.
    Psychopharmacology (Berl). 2025;242:2021-2033.
    PubMed         Abstract available
    
    

    
    Sci Rep

29. WANG D, Ai L, Tan H, Yan Y, et al
    A urinary DNA methylation assay using two genes enables noninvasive detection and prognostic prediction in urothelial carcinoma.
    Sci Rep. 2025;15:31281.
    PubMed         Abstract available
    
    

    
    World J Urol

30. VOLZ Y, Eismann L, Westhofen T, Pyrgidis N, et al
    Physical activity matters: prognostic impact of preoperative functioning scores in patients undergoing radical cystectomy.
    World J Urol. 2025;43:512.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.